Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000893220-02-000298
Filing Date
2002-03-22
Accepted
2002-03-22 00:00:00
Documents
7
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K - CELL PATHWAYS, INC. w58427e10-k405.txt 10-K405 332748
3 DISTRIBUTION AGREEMENT w58427ex10-4.txt EX-10.4 65104
4 RESTRICTED STOCK GRANT w58427ex10-24.txt EX-10.24 9325
5 NON-QUALIFIED STOCK OPTION AGREEMENT w58427ex10-25.txt EX-10.25 21450
6 SUBSIDIARIES w58427ex22-1.txt EX-22.1 251
7 CONSENT OF ARTHUR ANDERSEN LLP w58427ex23-1.txt EX-23.1 662
8 ISSUER LETTER CONCERNING AUDITOR REPRESENTATION w58427ex99-1.txt EX-99.1 1592
  Complete submission text file 0000893220-02-000298.txt   433500
Mailing Address 702 ELECTRONIC DRIVE 702 ELECTRONIC DRIVE HORSHAM PA 19044
Business Address 702 ELECTRONIC DRIVE HORSHAM PA 19044 2157063800
CELL PATHWAYS INC /DE (Filer) CIK: 0001066284 (see all company filings)

EIN.: 232969600 | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-24889 | Film No.: 02582359
SIC: 2834 Pharmaceutical Preparations